Publication | Closed Access

Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo

AsthmaSuperior EfficacyAntiproliferative EffectFibrosisMedicineImmunologyPathologyBronchial NeoplasmPulmonary FibrosisFibroblast Growth FactorLung TransplantationCell Transplantation